The COPD Foundation and ViiMed recently announced at the European Respiratory Society International Congress in Amsterdam, the…
Articles by Patrícia Silva, PhD
GlaxoSmithKline (GSK) and Theravance, Inc. recently announced in a press release their plans to file for a joint-supplemental Japanese…
Recent data obtained from a study published in the International Journal of Chronic Obstructive Pulmonary Disease entitled…
Theravance Biopharma, Inc. and Mylan MYL recently announced the commencement of a new phase III clinical program to evaluate…
Minnesota Health Solutions Corporation (MHS) recently announced a partnership with Novu, an SaaS-based consumer engagement platform designed to align consumers and…
Prescribing bronchodilators for patients with chronic obstructive pulmonary disease (COPD) with varying levels of disease severity can be a difficult task…
The use of short-acting-beta-2-agonists (SABA) has been associated with prediction of increased risks of chronic obstructive pulmonary disease (COPD) exacerbations…
In a recent article published in the Polish Archives of Internal Medicine, Richard ZuWallack from the Department…
CSL Behring, a global leader in the plasma protein therapeutics industry, has just announced its breakthrough maintenance treatment for patients with…
Boehringer Ingelheim recently released a report on the company’s findings from the Phase IIIb OTEMTO 1 (NCT01964352)…